United States · Investor

Arboretum Ventures

Last cheque observed Mar 2026; 54 cheques on record.

Deploying nowNew fund $137M, Jun 2022VC firm

Series ASeries BGrowthMedical_devicesLife_science_tools_diagnosticsTech_enabled_care_delivery

Deploying now
33%of best year1cheques in 12 months, 54 on record
Since the last cheque220days00hrs00min00sec
Median round$26MRounds led2 of 54Sole investor5 roundsExits6 from the portfolioMostly inUnited States, 98%
Pitch Arboretum Ventures

Arboretum Ventures highlights

  1. 01

    1 cheques in the last 12 months

  2. 02

    Mostly Series B and Series A: 56% of its rounds

  3. 03

    Sole investor in 5 rounds, median $12M

  4. 04

    6 exits from the portfolio

What they do

A healthcare venture capital firm rooted in the MidwestFrom their own website
Type
VC firm (from a list, unverified)
Cheque size
Not stated
Stages
Series ASeries BGrowth
Sectors
Medical_devicesLife_science_tools_diagnosticsTech_enabled_care_delivery
Based in
Ann Arbor, United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first54 appearances

  1. 2026

    1 round

  2. Mar
    EndogenexSeries C · US · Arboretum Ventures$50MLed
  3. 2025

    2 rounds

  4. Jun
    Akadeum Life SciencesGrowth · US · Firms' own news pages$20MWith 4 others
  5. Jun
    Allay TherapeuticsSeries D · US · Firms' own news pages$58MWith 14 others
  6. 2019

    1 round

  7. Apr
    Fifth EyeSeries A · US · FinSMEs$12MLed
  8. 2018

    4 rounds

  9. Dec
    SonarMDUS · FinSMEs$10MWith 1 other
  10. May
    StrataSeries B · US · FinSMEs$26MWith 5 others
  11. Apr
    Cardiac DimensionsSeries B · US · FinSMEs$39MWith 6 others
  12. Jan
    Pear TherapeuticsSeries C · US · Businesswire$64MWith 5 others
  13. 2017

    1 round

  14. Jan
    Pear TherapeuticsSeries B · US · FinSMEs$50MWith 5 others
  15. 2016

    2 rounds

  16. Jul
    nVision MedicalSeries B · US · Finance$12MSole investor
  17. Jun
    Si-BoneUS · Massdevice$20MSole investor
  18. 2015

    3 rounds

  19. Oct
    IntellicytVenture · US$7.4MWith 3 others
  20. Sept
    Delphinus Medical TechnologiesSeries C · US$40MWith 5 others
  21. Mar
    Cardiac DimensionsVenture · US$15MWith 4 others
  22. 2014

    4 rounds

  23. Oct
    My Health DirectVenture · US$8.0MWith 2 others
  24. Oct
    Cardiac DimensionsVenture · US$8.5MSole investor
  25. Aug
    Rethink AutismSeries C · US$10MWith 3 others
  26. Apr
    NeuMoDx MolecularSeries B · US$21MWith 3 others
  27. 2013

    6 rounds

  28. Sept
    ADVANCE MedicalGrowth · US · pehub.com$20MWith 2 others
  29. Jul
    ArborMetrixSeries B · US · finsmes.com$7.0MWith 2 others
  30. May
    Fidelis SeniorCareSeries A · US · pevc.dowjones.com$21MWith 1 other
  31. May
    IntellicytVenture · US · finsmes.com$8.0MWith 3 others
  32. Apr
    Esperion TherapeuticsVenture · US · businesswire.com$33MWith 5 others
  33. Feb
    BAROnovaSeries C · US · prnewswire.com$27MWith 5 others
  34. 2012

    5 rounds

  35. Nov
    Tangent Medical TechnologiesSeries B · US · sec.gov$8.6MWith 2 others
  36. May
    Sonitus TechnologiesVenture · CA · sec.gov$34KWith 3 others
  37. May
    Sonitus MedicalSeries D · US · sonitusmedical.com$25MWith 5 others
  38. Mar
    Uptake MedicalSeries C · US · sec.gov$40MWith 6 others
  39. Feb
    CervilenzSeries A · US · onbiovc.com$8.3MWith 1 other
  40. 2011

    5 rounds

  41. Nov
    Advanced ICU CareSeries D · US · icumedicine.com$8.0MWith 3 others
  42. Nov
    Tangent Medical TechnologiesSeries A · US · businesswire.com$4.5MWith 1 other
  43. Oct
    NxTheraSeries B · US · fis.dowjones.com$22MWith 2 others
  44. Apr
    WellfountSeries A · US · prweb.com$6.0MSole investor
  45. Apr
    My Health DirectSeries B · US · jsonline.com$4.0MWith 1 other
  46. 2010

    4 rounds

  47. Nov
    PathCentralSeries B · US · finsmes.com$10MWith 2 others
  48. Oct
    Accuri CytometersSeries E · US · onbiovc.com$6.0MWith 5 others
  49. Jul
    Delphinus Medical TechnologiesSeries A · US · onbiovc.com$8.0MWith 3 others
  50. Jul
    Uptake MedicalSeries B · US · uptakemedical.com$18MWith 5 others
  51. 2009

    3 rounds

  52. Oct
    CardioMEMSSeries F · US · onbiovc.com$22MWith 9 others
  53. Aug
    Accuri CytometersSeries D · US · onbiovc.com$4.0MWith 6 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration9 named

AMAmanda M. HeinrichManageriFiling they signed
DMDaniel Mclean KidleManaging MemberiFiling they signed
JLJan Lynn GarfinkleChief Executive OfficeriForm ADV
MLMarcy Lynn MarshallChief Financial OfficeriForm ADV
NJNicole J. WalkerManaging MemberiFiling they signed
PEPaul Ernest MccreadieManager, Arboretum Investment Manager IV, LLCiForm ADV
RJRobert J. CesaroManageriFiling they signed
TMThomas Michael ShehabManager, Arboretum Investment Manager V, LLCiForm ADV
TBTimothy Bruce PetersenManager, Arboretum Investment Manager, LLCiForm ADV

We also hold 21 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

$605Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
Legal name
Arboretum Ventures, LLC
SEC number
CRD 325307

What they claim to have backed

From their own portfolio page (on their website)

0 of 1 we have independently watched raise

Cookiedatabase

Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.

Exits from the portfolio

Companies it backed that were later bought or listed6 in all

PathCentralBought by XIFINUndisclosedAug 2013
Accuri CytometersBought by (Becton, Dickinson and Company)UndisclosedMar 2011
HandyLabBought by Becton Dickinson$275MOct 2009
NeoGuide SystemsBought by Intuitive SurgicalUndisclosedJun 2009
InogenListed$86MDec 2008
CardioMEMSBought by St. Jude MedicalUndisclosedNov 2003

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Arboretum Ventures. A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies Arboretum Ventures put money into.

On podcasts

1 episode naming Arboretum Ventures in the title.

Quick answers about Arboretum Ventures

What does Arboretum Ventures invest in?

Arboretum Ventures invests most often at Series B and Series A (56% of the rounds on record), in sectors such as Medical_devices, Life_science_tools_diagnostics and Tech_enabled_care_delivery.

How active is Arboretum Ventures?

54 investments on record, 1 of them in the last 12 months, and it led 2. The most recent was in Mar 2026.

What has Arboretum Ventures invested in recently?

Its most recent investments on record: Endogenex (Series C, Mar 2026), Akadeum Life Sciences (Growth, Jun 2025) and Allay Therapeutics (Series D, Jun 2025).

How big are Arboretum Ventures's cheques?

The median round it joins is $26M.

Does Arboretum Ventures lead rounds?

Sometimes: it led 2 of its 54 investments on record (4%).

Where does Arboretum Ventures invest?

Most of the companies it backs are in the United States (98%).

Is Arboretum Ventures investing now?

Yes: it is actively investing, with 1 investments in the last 12 months.

Who does Arboretum Ventures invest alongside?

Most often Baird Capital (6 rounds together), Chrysalis Ventures (5 rounds together) and ONSET Ventures (5 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it